Bausch Health Companies | Zinsaufwendungen Für Schuld



Interest Expense On Debt Veränderung Datum
Amgen USD 694M 29M 2025-06
ANI Pharmaceuticals USD 5.44M 46K 2025-06
Aurora Cannabis CAD 1.29M 768K 2024-12
Bausch Health Companies USD 465M 135M 2025-06
Biogen USD 72.6M 12.6M 2025-06
Bristol-Myers Squibb USD 485M 9M 2025-06
Canopy Growth CAD 16.77M 4.51M 2024-12
Corcept Therapeutics 6M 6M 2024-06
Danaher USD 71M 1000K 2025-06
Drreddys Laboratories INR 817M 60M 2024-12
Eli Lilly USD 249M 5.3M 2025-06
Gilead Sciences USD 254M 6M 2025-06
Novo Nordisk 4.96B 225M 2025-06
Pacira USD 3.82M 110K 2025-06
Perrigo 39.6M 600K 2025-06
Prestige Brands USD 10.2M 275K 2025-06
Supernus Pharmaceuticals USD 0 0 2024-12
Vertex Pharmaceuticals USD 3.7M 900K 2025-06
Zoetis USD 53M 1000K 2025-06


Bausch Health Companies Zinsaufwendungen Für Schuld - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.